INTRODUCTION
Delays in the identification, transfer, and management of critically ill patients during the first six hours after admission with sepsis to the ICU have been associated with higher mortality rates. 2 The timeliness of onset of treatment became a more important issue when Rivers and colleagues 3 were able to demonstrate a significant mortality benefit when hemodynamic optimization was provided within the first few hours of sepsis identification. If left untreated, sepsis can progress to septic shock, and this transition occurs most often within the first 24 hours of hospitalization.
TREATMENT
Because the disease progresses so rapidly, early and aggressive treatment is essential. Early antimicrobial therapy is recommended with broad coverage initially that is tailored to the potential source of infection and according to local hospital sensitivity and resistance patterns.
Early goal-directed therapy (EGDT) aims to restore the balance between oxygen supply and demand in cases of severe sepsis or septic shock within the first six hours of care. EGDT is an algorithmic approach of hemodynamic optimization and Other forms of treatment include volume therapy, vasoactive agents, administration of erythrocytes, inotropic therapy, and decreasing oxygen consumption.
ADJUNCTIVE THERAPIES
Several additional therapies initiated within the first 24 hours after identification of severe sepsis and septic shock have demonstrated a mortality benefit. Early implementation of these therapies may improve patients' survival, since they may wait several hours or even days before transfer to an ICU. These therapies include steroid therapy, activated protein C, protective lung strategies, and tight glycemic control.
CONCLUSION
Outcomes are optimized through early recognition during the first several hours of severe sepsis and septic shock along with prompt resuscitation. Other therapies that can provide a mortality benefit include the administration of corticosteroids, activated protein C, mechanical ventilation with low tidal volumes, and tight glycemic control. Emphasizing appropriate triage to ensure prompt diagnosis of the high-risk patient is vital to launch a coordinated and cooperative effort by the care team. The pathogenic, diagnostic, and therapeutic landscape of sepsis is no longer limited within the ICU, as many patients from other portals of entry to care progress to severe disease.
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